OncShare recently launched the first of its KeyPoints summaries – this time for RET fusion-positive NSCLC – but what is KeyPoints all about?

It’s a summary of the key points that oncologists need to know for a given biomarker/tumour type.  Authored by experts, the simple concept behind KeyPoints is “if you, as the expert, had 5 minutes with a practising oncologist who is not as close to the developing science as you are, what would they need to know?”

Designed for consumption in 5 minutes or less, KeyPoints complements longer forms of independent medical education.  References are included for those requiring further reading.

KeyPoints content is 100% independent medical education, funded directly by OncShare and/or by fully independent grants from the pharmaceutical industry.

Although not accredited, content is developed with a focus on accuracy, fairness and balance and aims to provide practical learning based on experts’ experience, offering more than oncologists can get from guidelines alone. 

As media is now globally accessible, KeyPoints is designed for a global audience, whilst recognising that practice can vary according to country, region and funding mechanism.